Clinical Trial Update: UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of UCD19 CAR T therapy in adults with B-cell acute lymphoblastic leukemia who are MRD-positive in CR1, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• UCD19 CAR T therapy

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING